Key result
Betaxolol hydrochloride and extended-release metoprolol tartrate achieved mean systolic trough-to-peak ratios of 72.84% and 70.59%, respectively, in patients with newly diagnosed hypertension.
Why the study?
Does betaxolol hydrochloride compared to extended-release metoprolol tartrate provide a different trough-to-peak ratio in patients with newly diagnosed hypertension?
RCT
Open-label
randomized
Does betaxolol hydrochloride compared to extended-release metoprolol tartrate provide a different trough-to-peak ratio in patients with newly diagnosed hypertension?
Both betaxolol and extended-release metoprolol tartrate demonstrate trough-to-peak ratios >66%, supporting their efficacy for once-daily administration in hypertension.
Answers are grounded in this paper and cite their sources.
Both beta-blockers may support once-daily dosing; leaves open comparative outcome trials in hypertension.
INTRODUCTION: The drug can be administered once a day, if the trough-to-peak ratio (T/P) exceeds 50-66%. The objective of this work was to determine and compare the T/P ratio for betaxolol hydrochloride and for extended-release metoprolol tartrate. METHODS: An open, randomized, prospective, comparative clinical study. The 24-h ambulatory blood pressure was measured with a SpaceLab 90207 automatic instrument (Redmond, Washington, USA) before and after 3 months of beta-blocker treatment. In order to determine the peak value, the individual maximum hourly mean blood pressure reduction was determined in the 3 to 6-h post-dose interval. For the determination of the trough value, the individual hourly mean blood pressure decrease in the 23-h post-dose interval, minimal 30 min after getting up in the morning was used. The T/P ratio was calculated as the mean of individual T/P ratios with statistical description of standard deviation (SD) and 95% confidence intervals (CIs). RESULTS: Betaxolol hydrochloride reduced the mean peak systolic blood pressure value by 17.87+/-8.32 mmHg, the mean peak diastolic blood pressure value by 16.07+/-6.65 mmHg, the mean trough systolic blood pressure value by 11.83+/-5.98 mmHg and the mean trough diastolic blood pressure value by 11.33+/-6.74 mmHg. The mean T/P ratio was calculated as 72.84+/-33.32% (95% CI, 60.40-85.285%) for systolic blood pressure and as 71.57+/-29.35% (95% CI, 60.62-82.53%) for diastolic blood pressure. Metoprolol reduced the mean peak systolic blood pressure value by 16.70+/-10.54 mmHg, the mean peak diastolic blood pressure value by 14.20+/-8.67 mmHg, the mean trough systolic blood pressure value by 11.30+/-9.12 mmHg and the mean trough diastolic blood pressure value by 10.00+/-8.38 mmHg. The mean T/P ratio was calculated as 70.59+/-31.66% (95% CI, 58.76-82.41%) for systolic blood pressure and as 66.95+/-31.60% (95% CI, 55.15-78.75%) for diastolic blood pressure. CONCLUSION: The T/P ratio determined for betaxolol hydrochloride and extended-release metoprolol tartrate is higher than 66%. This ratio guarantees a satisfactory 24-h effect of both the above-mentioned drugs.
No takes yet. Share an insight, caveat, or question.
Souček et al. (2006) conducted an RCT in newly diagnosed hypertension. Betaxolol hydrochloride vs. Extended-release metoprolol tartrate was evaluated on Trough-to-peak (T/P) ratio for systolic blood pressure. Betaxolol hydrochloride and extended-release metoprolol tartrate achieved mean systolic trough-to-peak ratios of 72.84% and 70.59%, respectively, in patients with newly diagnosed hypertension.
Synapse has enriched 10 related papers. Consider them for comparative context: